보건복지부 영문홈페이지

‘Global Training Hub for Biomanufacturing’

Launches 2024 Introductory Course

for Biologics Development and Manufacturing

- Entering its third year since its inception in July 2022 -

- 155 from 49 countries and 20 Korean trainees (a total of 175 participants) -

- Conducted by the International Vaccine Institute at Seoul National University Siheung Campus for two weeks, starting from June 3 -

The Ministry of Health and Welfare (Minister Cho KyooHong) announced that from June 3 to 14, a two-week introductory course for biologics development and manufacturing of the “Global Training Hub for Biomanufacturing (GTH-B),” which aims to enhance vaccine production capacity in low- and middle-income countries, including Korea, will be held at Seoul National University Siheung Campus in collaboration with the World Health Organization (WHO).

GTH-B was established in February 2022 by the Ministry of Health and Welfare and the World Health Organization, marking its third anniversary this year, to address the global vaccine disparity highlighted by the COVID-19 pandemic and to create a safer world against infectious diseases.

This training will involve 155 trainees in the biomanufacturing field from foreign companies across 49 nations, alongside 20 individuals, including employees from bio enterprises and pharmaceutical graduate students in Korea. Participants will receive comprehensive education covering the entire vaccine production cycle theory, discussions, case studies, visits to Korean industry sites, and networking opportunities. The International Vaccine Institute (IVI) conducts the training.

* The International Vaccine Institute (IVI), founded in 1997 and headquartered in Korea, is the first international organization focused on the discovery, development, and distribution of safe, effective, and affordable vaccines to alleviate the suffering caused by infectious diseases in low- and middle-income countries.

Since its inception, GTH-B has trained 754 participants from 43 countries in 2022 and 1,187 participants from 54 countries (including 59 Korean participants) in 2023. This year, the hub plans to provide an array of training programs, including theoretical and practical sessions, on-site consultation, as well as online courses, to approximately 1,300 participants. Serving as the hub to foster global workforce, Korea will continue to take a pivotal role in the global biohealth sector. ///